{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:46:51Z","timestamp":1782053211195,"version":"3.54.5"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1253\/circj.cj-09-0008","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T06:01:22Z","timestamp":1248415282000},"page":"1403-1407","source":"Crossref","is-referenced-by-count":20,"title":["Coagulation Activity is Increased in the Left Atria of Patients With Paroxysmal Atrial Fibrillation During the Non-Paroxysmal Period  Comparison With Chronic Atrial Fibrillation"],"prefix":"10.1253","volume":"73","author":[{"given":"Hirohiko","family":"Motoki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Izawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setsuo","family":"Kumazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uichi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stroke Prevention in Atrial Fibrillation Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639-647.","DOI":"10.7326\/0003-4819-128-8-199804150-00005"},{"key":"2","unstructured":"2. Odell JA, Blackshear JL, Davies E, Byrne WJ, Kollmorgen CF, Edwards WD, et al. Thoracoscopic obliteration of the left atrial appendage: Potential for stroke reduction? Ann Thorac Surg 1996; 61: 565-569."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.","DOI":"10.1161\/01.STR.22.8.983"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lachner TE, Battis GN. Use of Warfarin for nonvalvular atrial fibrillation in nursing home patients. Arch Fam Med 1995; 4: 1017-1026.","DOI":"10.1001\/archfami.4.12.1017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Randall S, Daniel S. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998; 97: 1231-1233.","DOI":"10.1161\/01.CIR.97.13.1231"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mitusch R, Siemens HJ, Garbe M, Wagner T, Sheikhzadeh A, Diederich KW. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996; 75: 219-223.","DOI":"10.1055\/s-0038-1650247"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 1999; 30: 2547-2553.","DOI":"10.1161\/01.STR.30.12.2547"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation: Effects of cardioversion and return of left atrial function. Eur Heart J 2001; 22: 1741-1747.","DOI":"10.1053\/euhj.2000.2531"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Asakura H, Hifumi S, Jokaji H, Saito M, Kumabashiri I, Uotani C, et al. Prothrombin fragment F1+2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis 1992; 3: 469-473.","DOI":"10.1097\/00001721-199203040-00015"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00427-5"},{"key":"11","unstructured":"11. Thibault B, Talajic M, Dubuc M, Guerra P, Gagné P, Roy D, et al; Canadian Trial of Atrial Fibrillation. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience. Can J Cardiol 2004; 20: 195-199."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.","DOI":"10.1056\/NEJMoa021328"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281415"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90062-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamamoto K, Ikeda U, Furuhashi K, Irokawa M, Nakayama T, Shimada K. The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 1993; 25: 1634-1640.","DOI":"10.1016\/0735-1097(95)00049-A"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kajimoto H, Nakazawa M, Murasaki K, Mori Y, Tanoue K, Kasanuki H, et al. Increased thrombogenesity in patients with cyanotic congenital heart disease. Circ J 2007; 71: 948-953.","DOI":"10.1253\/circj.71.948"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1573"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iga K, Izumi C, Inoko M, Kitaguchi S, Himura Y, Gen H, et al. Increased thrombin-antithrombin III complex during an episode of paroxysmal atrial fibrillation. Int J Cardiol 1998; 66: 153-156.","DOI":"10.1016\/S0167-5273(98)00211-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamaji T, Ishibashi M, Nakaoka H, Imataka K, Amano M, Fujii J. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmia. Lancet 1985; 1: 1211.","DOI":"10.1016\/S0140-6736(85)92883-1"},{"key":"20","unstructured":"20. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO\/IDF consultation. Geneva, Switzerland: WHO Press; 2006."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61233-1"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01125-1"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039327.11661.16"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000102969.09658.F2"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.538108"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000183735.09871.61"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yamashita T, Sekiguchi A, Kato T, Tsuneda T, Iwasaki YK, Sagara K, et al. Angiotensin type 1 receptor blocade prevents endocardial dysfunction of rapidly paced atria in rats. J Renin Angiotensin Aldosterone Syst 2007; 8: 127-132.","DOI":"10.3317\/jraas.2007.021"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.080"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Roger EP, Richard WH, John G, Eng G, Geoff H, Joseph JS. Determinants of increased regional left atrial coagulation activity in patients with mittal stenosis. Circulation 1996; 94: 331-339.","DOI":"10.1161\/01.CIR.94.3.331"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kamath S, Blann AD, Chin BS, Lip GY. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indiced of thrombogenesis and platelet activation in atrial fibrillation. J Am Coll Cardiol 2002; 40: 484-490.","DOI":"10.1016\/S0735-1097(02)01984-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nozawa T, Inoue H, Iwasa A, Okumura K, Jong-dae L, Shimizu A, et al. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Circ J 2004; 68: 29-34.","DOI":"10.1253\/circj.68.29"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90278-1"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmia in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-227.","DOI":"10.1161\/01.CIR.89.1.224"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/8\/73_CJ-09-0008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T03:48:53Z","timestamp":1616644133000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/8\/73_CJ-09-0008\/_article"}},"subtitle":["Comparison With Chronic Atrial Fibrillation"],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-09-0008","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}